CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...